Loading insider details...
Beta
Latest Form 4 (Jun 26, 2026): Grant/Award of 4,392 AXGN shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 26, 2026 | Axogen, Inc. (AXGN) | Grant/Award | 4,392 | n/a |
| Jun 23, 2026 | Axogen, Inc. (AXGN) | Exercise/Conversion | 14,150 | n/a |
| Jun 5, 2026 | Xeris Biopharma Holdings, Inc. (XERS) | Sale | 15,000 | $91.4K |
| May 26, 2026 | Verastem, Inc. (VSTM) | Grant/Award | 36,000 | n/a |
| May 8, 2026 | Axogen, Inc. (AXGN) | Exercise/Conversion | 11,050 | $77.8K |
| Dec 19, 2025 | Xeris Biopharma Holdings, Inc. (XERS) | Sale | 135,400 | $977.0K |
| Dec 10, 2025 | Axogen, Inc. (AXGN) | Sale | 11,802 | $368.9K |
| Aug 15, 2025 | Xeris Biopharma Holdings, Inc. (XERS) | Sale | 107,500 | $786.5K |
| Jun 20, 2025 | Axogen, Inc. (AXGN) | Grant/Award | 14,150 | n/a |
| Jun 11, 2025 | Axogen, Inc. (AXGN) | Sale | 4,073 | $43.2K |